 |
2′-O-(2-methoxyethyl)phosphorothioate antisense oligonucleotide |
|---|---|
| Trade Name | |
| Orphan Indication | Acromegaly |
| USA Market Approval | USA |
| USA Designation Date | 2016-05-10 00:00:00 |
| Sponsor | Antisense Therapeutics Limited;6 Wallace Avenue, TOORAK VIC 3142;Trevose |
Related Access Program